What does CUSIP 62921N105 represent in this 13F holders report?

CUSIP 62921N105 is the security identifier for NGM - NGM BIOPHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held NGM - NGM BIOPHARMACEUTICALS INC - COM in Q1 2024?

70 institutional investors reported NGM - NGM BIOPHARMACEUTICALS INC - COM for Q1 2024. Use the holders table for investor-level position and value details.

NGM BIOPHARMACEUTICALS INC - COM (NGM)

CUSIP: 62921N105

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / COM
Total 13F shares: 34,591,504
Share change: -6,470,479
Total reported value: $54,999,572
Put/Call ratio: 25%
Price per share: $1.59
Number of holders: 70
Value change: -$5,774,913
Number of buys: 28
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 62921N105:

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q1 2024

As of 31 Mar 2024, NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,591,504 shares. The largest 10 holders included Column Group LLC, BlackRock Inc., VANGUARD GROUP INC, StepStone Group LP, Euclidean Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, Trium Capital LLP, STATE STREET CORP, ADAR1 Capital Management, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.